Low/Intermediate PCa Video Chat, January 12, 2026
Low/Intermediate PCa Video Chat, January 12, 2026
AnCan is grateful to the following sponsors for making this recording possible: Novartis, Johnson and Johnson, Telix, Blue Earth Diagnostics, and Foundation Medicine.
WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.
- Men (Only) Speaking Freely…1st & 3rd Thursdays @ 8.00 pm Eastern https://ancan.org/men-speaking-freely/
- Veterans Healthcare Navigation… 1st & 3rd Tuesdays @ 8.00 pm Eastern https://ancan.org/veterans/
- You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/
- Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/
Editor’s Pick: Using DECIPHER genomic testing to assess cancer agressiveness. (bj)
Topics Discussed
Cancer discovery following an aquablation procedure for an enlarged prostate; post-procedure PSA and MRI testing to monitor remaining cancer; comparing transrectal and transperineal biopsy safety and access; importance of consulting genitourinary oncologists at major centers; using specialists like Dr. Epstein for pathology second opinions; weighing active surveillance against the risk of cancer progression; discussion of MR LINAC, proton, and photon radiation technologies; using PSMA PET scans to detect potential lymph node involvement; selecting high-volume urban medical centers over smaller clinics; using DECIPHER genomic testing to assess cancer agressiveness.
Chat